Physician

Mohamed S Ahmed, M.D.

According to 2025 Medicare claims, Mohamed Ahmed, M.D. (NPI: 1598776270) practices cardiology in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is SOUTHWEST CARDIOVASCULAR ASSOCIATES AHMED ALFAFARA AND PRASAD LTD (NPI: 1205883162; TIN: 471878079) and primary practice location at 86442-7906.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 3,418 HCPCS/CPT codes, and received $281,034 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,468 prescription claims across 572 beneficiaries totaling $634,750 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 31 claims. Open Payments data shows 34 records totaling $1,105. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $625,946 to $281,034. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $234,620 to $634,750. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $8,768 and ending at $8,589.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,862	7,397	$625,946
2016	2,191	7,463	$605,715
2017	2,204	6,509	$522,093
2018	1,947	6,191	$606,111
2019	1,685	5,378	$439,442
2020	1,469	4,566	$388,542
2021	1,188	5,205	$402,800
2022	866	3,576	$255,498
2023	693	3,752	$345,865
2024	685	3,418	$281,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	595	4,166	$234,620
2016	614	4,271	$289,028
2017	627	4,213	$275,903
2018	615	4,242	$327,790
2019	577	3,914	$420,226
2020	570	3,835	$480,957
2021	579	3,478	$482,339
2022	534	3,234	$522,495
2023	568	3,262	$588,479
2024	572	3,468	$634,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	85	$4,604
2016	N/R	18	$1,150
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	31	$1,923
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	118	125	$122
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	93	93	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	347	755	$87
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	277	284	$85
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	317	416	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	139	9,873	$187,917
Entresto	Sacubitril/Valsartan	79	5,606	$122,223
Xarelto	Rivaroxaban	81	6,510	$117,691
Brilinta	Ticagrelor	74	4,320	$62,156
Jardiance	Empagliflozin	33	2,430	$45,805

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$1,105	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamed S. Ahmed, M.D.?

Tedicare shows public-source Medicare data for Mohamed S. Ahmed, M.D. (NPI 1598776270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed S. Ahmed, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohamed S. Ahmed, M.D.?

Mohamed S. Ahmed, M.D. is linked to SOUTHWEST CARDIOVASCULAR ASSOCIATES AHMED ALFAFARA AND PRASAD LTD (billing NPI 1205883162) in the available physician profile data.

Does Mohamed S. Ahmed, M.D. have Open Payments data?

Mohamed S. Ahmed, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.